首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial
【2h】

The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial

机译:针对患者量身定制的干预计划以增强社区药房对降压药物的依从性(成本-效果):一项随机对照试验的研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundMedication non-adherence is a complex health care problem. Due to non-adherence, substantial numbers of cardiovascular patients benefit from their medication to only a limited extent. In order to improve adherence, a variety of pharmacist-led interventions have been developed. However, even the most effective interventions achieved only a modest positive effect. To be effective, interventions should be targeted at underlying barriers to adherence, developed in a systematic manner and tailored to specific features of a target group and setting. The current paper describes the design of the Cardiovascular medication non-Adherence Tailored Intervention (CATI) study aimed to evaluate the (cost-)effectiveness of a patient-tailored intervention programme in patients using antihypertensive medication.
机译:背景药物不依从是一个复杂的卫生保健问题。由于不坚持治疗,许多心血管患者只能在有限的程度上受益于他们的药物治疗。为了提高依从性,已经开发了各种药剂师主导的干预措施。但是,即使是最有效的干预措施也只能产生适度的积极效果。为有效起见,干预措施应针对依从性的潜在障碍,以系统的方式制定并针对目标人群和环境的特定特征进行调整。本论文描述了心血管药物非依从性量身定制的干预(CATI)研究的设计,旨在评估使用降压药物的患者量身定制的干预计划的(成本)效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号